Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site
Loading...
Full text at PDC
Publication date
2024
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Cell Press
Citation
Thompson A J, Wu N C, Canales A, Kikuchi C, Zhu X , Fernández de Toro B, Cañada F J, Worth C, Wang S , McBride R , Peng W , Nycholat C M , Jiménez-Barbero J, Wilson I A, Paulson J C. Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site. Cell Host Microbe. 2024 Feb 14; 32(2): 261–275.e4.
Abstract
Hemagglutinins (HAs) from human influenza viruses descend from avian progenitors that bind α2–3-linked sialosides, and must adapt to glycans with α2–6-linked sialic acids on human airway cells to transmit within the human population. Since their introduction during the 1968 pandemic, H3N2 viruses have evolved over the past five decades to preferentially recognize α2–6-sialoside receptors that are elongated through addition of poly-LacNAc. Using STD-NMR, X-ray crystallography, and solid-phase glycan microarrays, we show that more recent H3N2 viruses now make increasingly complex interactions with elongated receptors, while continuously selecting for strains maintaining this phenotype. This change is accompanied by an extension of the traditional receptor binding site to include residues in key antigenic sites on the surface of HA trimers. These results help explain the propensity for selection of antigenic variants, leading to vaccine mismatching, when H3N2 viruses are propagated in chicken eggs or cells that do not contain such receptors.